IBS – A Condition Often Treated with Component L4

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurring abdominal discomfort that occurs on average at least one day per week over the past three months. Diagnosis requires meeting at least two of the following criteria: 1) association with bowel movements, 2) alteration in stool frequency, 3) changes in stool appearance. Historically, IBS was not recognized as a distinct medical condition. Currently, diagnosis is based on the so-called Rome IV criteria. Variants include diarrhea-predominant, constipation-predominant, mixed, or unclassified forms. Diagnosis is made by a gastroenterologist. IBS is prevalent worldwide, particularly in developed nations, potentially linked to lifestyle factors. Women are more commonly affected than men, especially between ages 20–40. The condition may, but does not necessarily, have a familial component. IBS not only diminishes patients' quality of life but also imposes significant economic burdens on healthcare systems. Research from 2003 indicated that IBS is among the most frequent reasons for gastroenterology consultations and medical leave certificates issued by internists (J. M. Inadomi, M. B. Fennerty, D. Bjorkman 2003).

The primary indicators of irritable bowel syndrome (IBS) include abdominal pain and general discomfort associated with bowel movements. Pain may occur in various locations but is typically centered in the lower abdomen. In addition to pain, patients often experience excessive gas, a sensation of abdominal fullness, diarrhea, and/or constipation. The severity and nature of symptoms can fluctuate based on dietary intake, though individual responses vary. Beyond gastrointestinal issues, common symptoms encompass headaches, muscle aches, persistent fatigue, sleep disturbances, and psychological challenges. These symptoms should not be disregarded, as they may progress to more serious conditions over time. Alternating episodes of diarrhea and constipation can contribute to the development of hemorrhoids or other intestinal disorders. Furthermore, IBS negatively impacts patients' mental well-being, potentially leading to mood disturbances or even depression.

The origins of irritable bowel syndrome (IBS) are multifaceted and not fully understood. While no single definitive trigger for symptoms exists, several contributing factors have been identified: disruptions in the gut-brain axis, or neural networks connecting the digestive system to the central nervous system; dysbiosis, or microbial imbalance in the intestines, characterized by a reduction in beneficial bacteria such as Lactobacillus and Bifidobacterium, alongside an increase in harmful bacteria like Escherichia coli and Pseudomonas spp.; alterations in the Bacteroidetes-to-Firmicutes ratio; gastrointestinal infections that may lead to post-infectious IBS (IBS-PI); visceral hypersensitivity, or heightened pain perception in the gastrointestinal tract; genetic predispositions; and psychosocial factors. Stress is a key contributor, both triggering and exacerbating IBS symptoms. Two types of stress are recognized: acute stress, which stimulates adrenaline release and activates the "fight-or-flight" response, and chronic stress, which negatively impacts health and may contribute to IBS development. Intense emotions, traumatic experiences, depression, or anxiety disorders often worsen IBS symptoms. Given the inevitability of stress in modern life, emphasis is placed on stress management and mitigation techniques.

After diagnosing irritable bowel syndrome (IBS), a comprehensive therapeutic approach is necessary. In the differential diagnosis of IBS and inflammatory bowel diseases (IBD), identifying organic causes is crucial. In IBS treatment, the focus should be on alleviating symptoms and eliminating risk factors. Pharmacological treatment should be individually tailored, and the patient should be engaged in the therapeutic process. Collaboration with physicians, dietitians, psychologists, and other specialists can significantly improve the patient's quality of life.

A well-balanced diet is a crucial component in managing irritable bowel syndrome (IBS), as symptoms often correlate with dietary choices. A personalized nutrition plan should be developed, adhering to healthy eating principles such as regular meals, alcohol moderation, and avoidance of spicy and fatty foods. Proper hydration is equally important. For IBS patients, the low-FODMAP diet is the standard approach, targeting fermentable carbohydrates like fructose, lactose, fructans, galactooligosaccharides, and polyols. The diet involves three phases: elimination, reintroduction, and maintenance. The initial phase lasts 6–8 weeks, focusing on avoiding high-FODMAP foods. The second phase gradually reintroduces these foods to assess tolerance. The final phase ensures long-term adherence to tolerated foods. Dietary therapy should be supervised by a specialist to prevent deficiencies. Research, including studies by E. Halmos, supports the effectiveness of the low-FODMAP diet. Dietary adjustments are made based on accompanying symptoms such as bloating, diarrhea, or constipation. For constipation, a high-fiber diet, particularly with insoluble fiber, is recommended. In cases of diarrhea, a low-fiber, easily digestible diet is advised. For mixed or unclassified IBS, food choices depend on current symptoms. Additional food intolerances often complicate IBS, necessitating further dietary modifications.

Irritable bowel syndrome (IBS) is a prevalent chronic digestive disorder that can significantly impair daily functioning. Since the condition often has psychological roots, a holistic approach is necessary, involving lifestyle modifications and strict adherence to medical recommendations. Taking medications alone without professional guidance does not provide lasting relief. Collaborating with doctors, dietitians, and other specialists helps alleviate symptoms and improve overall well-being.